Articles with public access mandates - Jennifer Sharpe PotterLearn more
Not available anywhere: 3
Quality of life among women diagnosed with breast Cancer: A randomized waitlist controlled trial of commercially available mobile app‐delivered mindfulness training
KD Rosen, SM Paniagua, W Kazanis, S Jones, JS Potter
Psycho‐Oncology 27 (8), 2023-2030, 2018
Mandates: Susan G. Komen
Misuse of Prescribed Pain Medication in a Military Population—A Self-Reported Survey to Assess a Correlation With Age, Deployment, Combat Illnesses, or Injury?
S Ramirez, VS Bebarta, SM Varney, V Ganem, LA Zarzabal, JS Potter
American journal of therapeutics 24 (2), e150-e156, 2017
Mandates: US Department of Defense
Mindfulness predicts current risk of opioid analgesic misuse in chronic low back pain patients receiving opioid therapy
YR Villarreal, AL Stotts, SM Paniagua, K Rosen, M Eckmann, R Suchting, ...
Journal of Contextual Behavioral Science 18, 111-116, 2020
Mandates: US National Institutes of Health
Available somewhere: 63
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial
RD Weiss, JS Potter, DA Fiellin, M Byrne, HS Connery, W Dickinson, ...
Archives of general psychiatry 68 (12), 1238-1246, 2011
Mandates: US National Institutes of Health
Development of a definition of postacute sequelae of SARS-CoV-2 infection
T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ...
Jama 329 (22), 1934-1946, 2023
Mandates: US National Institutes of Health
Alterations in brain structure and functional connectivity in prescription opioid-dependent patients
J Upadhyay, N Maleki, J Potter, I Elman, D Rudrauf, J Knudsen, D Wallin, ...
Brain 133 (7), 2098-2114, 2010
Mandates: US National Institutes of Health
Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial
GE Woody, SA Poole, G Subramaniam, K Dugosh, M Bogenschutz, ...
Jama 300 (17), 2003-2011, 2008
Mandates: US National Institutes of Health
Gender differences in a clinical trial for prescription opioid dependence
RK McHugh, EE DeVito, D Dodd, KM Carroll, JS Potter, SF Greenfield, ...
Journal of substance abuse treatment 45 (1), 38-43, 2013
Mandates: US National Institutes of Health
Evaluating the impact of prescription drug monitoring program implementation: a scoping review
EP Finley, A Garcia, K Rosen, D McGeary, MJ Pugh, JS Potter
BMC health services research 17 (1), 1-8, 2017
Mandates: US Department of Defense, US National Institutes of Health
Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain
RD Weiss, JS Potter, ML Griffin, RK McHugh, D Haller, P Jacobs, ...
Journal of substance abuse treatment 47 (2), 140-145, 2014
Mandates: US National Institutes of Health
Long-term outcomes from the national drug abuse treatment clinical trials network prescription opioid addiction treatment study
RD Weiss, JS Potter, ML Griffin, SE Provost, GM Fitzmaurice, ...
Drug and alcohol dependence 150, 112-119, 2015
Mandates: US National Institutes of Health
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults
KM Gray, SC Sonne, EA McClure, UE Ghitza, AG Matthews, ...
Drug and alcohol dependence 177, 249-257, 2017
Mandates: US National Institutes of Health
Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study
JA Dreifuss, ML Griffin, K Frost, GM Fitzmaurice, JS Potter, DA Fiellin, ...
Drug and alcohol dependence 131 (1-2), 112-118, 2013
Mandates: US National Institutes of Health
Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement …
JS Potter, EN Marino, MP Hillhouse, S Nielsen, K Wiest, CP Canamar, ...
Journal of studies on alcohol and drugs 74 (4), 605-613, 2013
Mandates: US National Institutes of Health
International stakeholder community of pain experts and leaders call for an urgent action on forced opioid tapering
BD Darnall, D Juurlink, RD Kerns, S Mackey, B Van Dorsten, ...
Pain Medicine 20 (3), 429-433, 2019
Mandates: US National Institutes of Health
A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology
RD Weiss, JS Potter, SE Provost, Z Huang, P Jacobs, A Hasson, ...
Contemporary clinical trials 31 (2), 189-199, 2010
Mandates: US National Institutes of Health
Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth
D Warden, GA Subramaniam, T Carmody, GE Woody, A Minhajuddin, ...
Addictive behaviors 37 (9), 1046-1053, 2012
Mandates: US National Institutes of Health
Short term health-related quality of life improvement during opioid agonist treatment
B Nosyk, JW Bray, E Wittenberg, B Aden, AA Eggman, RD Weiss, J Potter, ...
Drug and alcohol dependence 157, 121-128, 2015
Mandates: US National Institutes of Health
Predictors of Abstinence: National Institute of Drug Abuse Multisite Buprenorphine/Naloxone Treatment Trial in Opioid-Dependent Youth
GA Subramaniam, D Warden, A Minhajuddin, MJ Fishman, ML Stitzer, ...
Journal of the American Academy of Child & Adolescent Psychiatry 50 (11 …, 2011
Mandates: US National Institutes of Health
Randomized multi-site trial of the Job Seekers’ Workshop in patients with substance use disorders
DS Svikis, L Keyser-Marcus, M Stitzer, T Rieckmann, L Safford, P Loeb, ...
Drug and alcohol dependence 120 (1-3), 55-64, 2012
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program